Regeneron Financial Statements (REGN)
|
|
|
|
Report date
|
|
|
07.02.2022 |
06.02.2023 |
05.02.2024 |
05.02.2025 |
04.02.2026 |
|
29.04.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
16 072 |
12 173 |
13 117 |
14 202 |
14 343 |
|
14 920 |
|
Operating Income, bln rub |
|
|
8 947 |
5 386 |
4 349 |
3 991 |
3 578 |
|
3 629 |
|
EBITDA, bln rub |
? |
|
9 669 |
5 260 |
4 693 |
5 318 |
5 818 |
|
5 745 |
|
Net profit, bln rub |
? |
|
8 075 |
4 338 |
3 954 |
4 413 |
4 505 |
|
4 423 |
|
|
OCF, bln rub |
? |
|
7 081 |
5 015 |
4 594 |
4 421 |
4 979 |
|
5 013 |
|
CAPEX, bln rub |
? |
|
551.9 |
590.1 |
926.4 |
755.9 |
898.4 |
|
857.5 |
|
FCF, bln rub |
? |
|
6 529 |
4 425 |
3 668 |
3 665 |
4 081 |
|
4 155 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
370.3 |
|
374.3 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
8.22% |
|
8.46% |
|
|
OPEX, bln rub |
|
|
4 401 |
5 082 |
6 524 |
8 241 |
8 664 |
|
8 985 |
|
Cost of production, bln rub |
|
|
2 724 |
1 705 |
2 245 |
1 971 |
2 101 |
|
2 306 |
|
R&D, bln rub |
|
|
2 622 |
3 056 |
3 987 |
5 233 |
5 850 |
|
6 261 |
|
Interest expenses, bln rub |
|
|
57.3 |
59.4 |
73.0 |
55.2 |
43.8 |
|
48.0 |
|
|
Assets, bln rub |
|
|
25 435 |
29 215 |
33 080 |
37 759 |
40 559 |
|
40 869 |
|
Net Assets, bln rub |
? |
|
18 769 |
22 664 |
25 973 |
29 354 |
31 257 |
|
31 424 |
|
Debt, bln rub |
|
|
2 700 |
2 701 |
2 703 |
2 704 |
2 706 |
|
2 706 |
|
Cash, bln rub |
|
|
5 695 |
7 742 |
10 845 |
9 013 |
8 605 |
|
8 754 |
|
Net debt, bln rub |
|
|
-2 995 |
-5 041 |
-8 142 |
-6 308 |
-5 899 |
|
-6 048 |
|
|
Ordinary share price, rub |
|
|
631.5 |
721.5 |
878.3 |
712.3 |
771.9 |
|
649.8 |
|
Number of ordinary shares, mln |
|
|
105.7 |
107.1 |
106.7 |
107.9 |
104.6 |
|
104.0 |
|
|
Market cap, bln rub |
|
|
66 752 |
77 272 |
93 714 |
76 860 |
80 738 |
|
67 575 |
|
EV, bln rub |
? |
|
63 757 |
72 231 |
85 572 |
70 552 |
74 838 |
|
61 528 |
|
Book value, bln rub |
|
|
18 762 |
21 749 |
24 935 |
28 205 |
30 000 |
|
30 137 |
|
|
EPS, rub |
? |
|
76.4 |
40.5 |
37.1 |
40.9 |
43.1 |
|
42.5 |
|
FCF/share, rub |
|
|
61.8 |
41.3 |
34.4 |
34.0 |
39.0 |
|
40.0 |
|
BV/share, rub |
|
|
177.5 |
203.1 |
233.7 |
261.4 |
286.8 |
|
289.8 |
|
|
EBITDA margin, % |
? |
|
60.2% |
43.2% |
35.8% |
37.4% |
40.6% |
|
38.5% |
|
Net margin, % |
? |
|
50.2% |
35.6% |
30.1% |
31.1% |
31.4% |
|
29.6% |
|
FCF yield, % |
? |
|
9.78% |
5.73% |
3.91% |
4.77% |
5.05% |
|
6.15% |
|
ROE, % |
? |
|
43.0% |
19.1% |
15.2% |
15.0% |
14.4% |
|
14.1% |
|
ROA, % |
? |
|
31.7% |
14.9% |
12.0% |
11.7% |
11.1% |
|
10.8% |
|
|
P/E |
? |
|
8.27 |
17.8 |
23.7 |
17.4 |
17.9 |
|
15.3 |
|
P/FCF |
|
|
10.2 |
17.5 |
25.6 |
21.0 |
19.8 |
|
16.3 |
|
P/S |
? |
|
4.15 |
6.35 |
7.14 |
5.41 |
5.63 |
|
4.53 |
|
P/BV |
? |
|
3.56 |
3.55 |
3.76 |
2.73 |
2.69 |
|
2.24 |
|
EV/EBITDA |
? |
|
6.59 |
13.7 |
18.2 |
13.3 |
12.9 |
|
10.7 |
|
Debt/EBITDA |
|
|
-0.31 |
-0.96 |
-1.73 |
-1.19 |
-1.01 |
|
-1.05 |
|
|
R&D/CAPEX, % |
|
|
475.1% |
517.9% |
430.3% |
692.3% |
651.2% |
|
730.2% |
|
|
CAPEX/Revenue, % |
|
|
3.43% |
4.85% |
7.06% |
5.32% |
6.26% |
|
5.75% |
|
| Regeneron shareholders |
